COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,971 Articles (22,604 medRxiv, 8,367 bioRxiv)

Most recent first Previous |  Page 526: Articles 5251-5260  | Next

DiffDomain enables identification of structurally reorganized topologically associating domains
Hua, D., Gu, M., Zhang, X., Du, Y., Xie, H., Qi, L., Du, X., Bai, Z., Zhu, X., Tian, D.
10.1101/2022.12.05.519135 — Posted: 2022-12-05
Covidscope: An atlas-scale COVID-19 resource for single-cell meta analysis at sample and cell levels
Yin, D., Cao, Y., Chen, J., Mak, C. L. Y., Yu, K. H. O., Lin, Y., Ho, J. W. K., Yang, J. Y. H.
10.1101/2022.12.03.518997 — Posted: 2022-12-05
Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane
Shi, W., Cai, Y., Zhu, H., Peng, H., Voyer, J., Rits-Volloch, S., Cao, H., Mayer, M. L., Song, K., Xu, C., Lu, J., Zhang, J., Chen, B.
10.1101/2022.12.05.519151 — Posted: 2022-12-05
Convergent evolution of the SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
Ito, J., Suzuki, R., Uriu, K., Itakura, Y., Zahradnik, J., Deguchi, S., Wang, L., Lytras, S., Tamura, T., Kida, I., Nasser, H., Shofa, M., Begum, M. M., Tsuda, M., Oda, Y., Fujita, S., Yoshimatsu, K., Ito, H., Nao, N., Asakura, H., Nagashima, M., Sadamasu, K., Yoshimura, K., Yamamoto, Y., Nagamoto, T., Schreiber, G., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Saito, A., Matsuno, K., Takayama, K., Tanaka, S., Fukuhara, T., Ikeda, T., Sato, K.
10.1101/2022.12.05.519085 — Posted: 2022-12-05
Enhanced Protection from SARS-CoV-2 Variants by MVA-Based Vaccines Expressing Matched or Mismatched S Proteins Administered Intranasally to hACE2 Mice
Cotter, C. A., Americo, J. L., Earl, P. L., Moss, B.
10.1101/2022.12.03.518963 — Posted: 2022-12-05
Deep mutational scanning to predict antibody escape in SARS-CoV-2 Omicron subvariants
Alcantara, M. C., Higuchi, Y., Kirita, Y., Matoba, S., Hoshino, A.
10.1101/2022.12.02.518937 — Posted: 2022-12-05
Bioinformatics techniques for efficient structure prediction of SARS-CoV-2 protein ORF7a via structure prediction approaches
Kazmi, A., Kazim, M., Aslam, F., Kazmi, S. M.-u.-H., Wahab, A., Mikhlef, R. M., Khizar, C., Kazmi, A., Wazir, N. U., Mainali, R. P.
10.1101/2022.12.03.518956 — Posted: 2022-12-05
Convergent evolution in SARS-CoV-2 Spike creates a variant soup that causes new COVID-19 waves.
Focosi, D., Quiroga, R., McConnell, S., Johnson, M. C., Casadevall, A.
10.1101/2022.12.05.518843 — Posted: 2022-12-05
New insights into the structure of Comirnaty Covid-19 vaccine: A theory on soft nanoparticles with mRNA-lipid supercoils stabilized by hydrogen bonds
Szebeni, J., Kiss, B., Bozo, T., Turjeman, K., Levi-Kalisman, Y., Barenholz, Y., Kellermayer, M.
10.1101/2022.12.02.518611 — Posted: 2022-12-05
A Generalized Multinomial Probabilistic Model for SARS-CoV-2 Infection Prediction and Public Health Intervention Assessment in an Indoor Environment
Li, V. O., Lam, J. C., Sun, Y., Han, Y., Chan, K., Wang, S.-s., Crowcroft, J., Downey, J., Zhang, Q.
10.1101/2022.12.02.22282697 — Posted: 2022-12-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).